Literature DB >> 21145370

Modulation of macrophage inflammatory profile in pregnant nonobese diabetic (NOD) mice.

Luciana Larocca1, Vanesa Hauk, Mario Calafat, Valeria Roca, Laura Fraccaroli, Ana Franchi, Rosanna Ramhorst, Claudia Pérez Leirós.   

Abstract

During normal early pregnancy circulating monocytes are recruited to the maternal-placental interface where they differentiate to macrophages expressing different functional phenotypes for the maintenance of tissue homeostasis. Pregnancy in the nonobese diabetic (NOD) mouse model presents some pathological features in the pre-diabetic stage. The aim of this work was to analyze the functional profile of peritoneal macrophages faced with inflammatory and phagocytic stimuli in early pregnant pre-diabetic NOD mice and their modulation by vasoactive intestinal peptide (VIP). Pregnant NOD mouse macrophages showed no basal NFκB activation, lower IL-12 and nitrites production compared with the macrophages from non-pregnant NOD mice. Their pro-inflammatory aberrant response to LPS and apoptotic cell challenge was reduced and VIP inhibited macrophage residual deleterious responses to apoptotic cells. A functional phenotype switch in macrophages during pregnancy in NOD mice and a promoting effect of VIP towards this regulatory phenotype would be in line with the central role of macrophages in the maternal-placental dialogue.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21145370     DOI: 10.1016/j.mce.2010.11.035

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  7 in total

1.  Vasoactive intestinal peptide/vasoactive intestinal peptide receptor relative expression in salivary glands as one endogenous modulator of acinar cell apoptosis in a murine model of Sjögren's syndrome.

Authors:  V Hauk; M Calafat; L Larocca; L Fraccaroli; E Grasso; R Ramhorst; C Pérez Leirós
Journal:  Clin Exp Immunol       Date:  2011-12       Impact factor: 4.330

2.  Vasoactive intestinal peptide suppresses macrophage-mediated inflammation by downregulating interleukin-17A expression via PKA- and PKC-dependent pathways.

Authors:  Wen-Zhuo Ran; Liang Dong; Chun-Yan Tang; Yong Zhou; Guo-Ying Sun; Tian Liu; Yong-Ping Liu; Cha-Xiang Guan
Journal:  Int J Exp Pathol       Date:  2015-05-05       Impact factor: 1.925

3.  Monocytes from Sjögren's syndrome patients display increased vasoactive intestinal peptide receptor 2 expression and impaired apoptotic cell phagocytosis.

Authors:  V Hauk; L Fraccaroli; E Grasso; A Eimon; R Ramhorst; O Hubscher; C Pérez Leirós
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

4.  VIP Regulates the Development & Proliferation of Treg in vivo in spleen.

Authors:  Anthony M Szema; Sayyed A Hamidi; Marc G Golightly; Todd P Rueb; John J Chen
Journal:  Allergy Asthma Clin Immunol       Date:  2011-11-29       Impact factor: 3.406

5.  Differential migration and activation profile of monocytes after trophoblast interaction.

Authors:  Esteban Grasso; Daniel Paparini; Vanesa Hauk; Gabriela Salamone; Claudia Perez Leiros; Rosanna Ramhorst
Journal:  PLoS One       Date:  2014-05-21       Impact factor: 3.240

Review 6.  Maternal Obesity and the Uterine Immune Cell Landscape: The Shaping Role of Inflammation.

Authors:  Lauren E St-Germain; Barbara Castellana; Jennet Baltayeva; Alexander G Beristain
Journal:  Int J Mol Sci       Date:  2020-05-27       Impact factor: 5.923

7.  VIP treatment prevents embryo resorption by modulating efferocytosis and activation profile of maternal macrophages in the CBAxDBA resorption prone model.

Authors:  Lucila Gallino; Guillermina Calo; Vanesa Hauk; Laura Fraccaroli; Esteban Grasso; Mónica Vermeulen; Claudia Pérez Leirós; Rosanna Ramhorst
Journal:  Sci Rep       Date:  2016-01-06       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.